ATE362107T1 - Verfahren und vorrichtungen zum quantitativen nachweis eines prostata-spezifischen membranantigens und anderer prostatamarker - Google Patents
Verfahren und vorrichtungen zum quantitativen nachweis eines prostata-spezifischen membranantigens und anderer prostatamarkerInfo
- Publication number
- ATE362107T1 ATE362107T1 AT01989101T AT01989101T ATE362107T1 AT E362107 T1 ATE362107 T1 AT E362107T1 AT 01989101 T AT01989101 T AT 01989101T AT 01989101 T AT01989101 T AT 01989101T AT E362107 T1 ATE362107 T1 AT E362107T1
- Authority
- AT
- Austria
- Prior art keywords
- prostate
- markers
- detection
- quantitative detection
- specific membrane
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
- G01N33/57407—Specifically defined cancers
- G01N33/57434—Specifically defined cancers of prostate
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
- C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6803—General methods of protein analysis not limited to specific proteins or families of proteins
- G01N33/6848—Methods of protein analysis involving mass spectrometry
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6803—General methods of protein analysis not limited to specific proteins or families of proteins
- G01N33/6848—Methods of protein analysis involving mass spectrometry
- G01N33/6851—Methods of protein analysis involving laser desorption ionisation mass spectrometry
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US25245200P | 2000-11-20 | 2000-11-20 |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE362107T1 true ATE362107T1 (de) | 2007-06-15 |
Family
ID=22956064
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT01989101T ATE362107T1 (de) | 2000-11-20 | 2001-11-16 | Verfahren und vorrichtungen zum quantitativen nachweis eines prostata-spezifischen membranantigens und anderer prostatamarker |
Country Status (9)
Country | Link |
---|---|
EP (1) | EP1390523B1 (de) |
JP (1) | JP2004536278A (de) |
KR (1) | KR20030066672A (de) |
CN (1) | CN1537170A (de) |
AT (1) | ATE362107T1 (de) |
AU (2) | AU4322102A (de) |
CA (1) | CA2428011A1 (de) |
DE (1) | DE60128404D1 (de) |
WO (1) | WO2002046448A2 (de) |
Families Citing this family (25)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20050215472A1 (en) | 2001-10-23 | 2005-09-29 | Psma Development Company, Llc | PSMA formulations and uses thereof |
AU2002356844C1 (en) | 2001-10-23 | 2010-03-04 | Amgen Fremont Inc. | PSMA antibodies and protein multimers |
GB0305656D0 (en) * | 2003-03-12 | 2003-04-16 | Bioinvent Int Ab | Screening assay |
US7425700B2 (en) | 2003-05-22 | 2008-09-16 | Stults John T | Systems and methods for discovery and analysis of markers |
US7696185B2 (en) * | 2006-03-14 | 2010-04-13 | Cancer Targered Technology LLC | Peptidomimetic inhibitors of PSMA, compounds comprising them, and methods of use |
JP4995194B2 (ja) * | 2006-05-10 | 2012-08-08 | あすか製薬株式会社 | 前立腺癌と良性前立腺過形成の鑑別法 |
US8586006B2 (en) * | 2006-08-09 | 2013-11-19 | Institute For Systems Biology | Organ-specific proteins and methods of their use |
CN101158666B (zh) * | 2006-10-08 | 2012-06-27 | 许洋 | 一种用含有抗体组的基质去捕获生物样品中生物标志的分析方法 |
CA2680556A1 (en) | 2007-03-12 | 2008-09-18 | Miraculins Inc. | Biomarkers of prostate cancer and uses thereof |
WO2008136912A1 (en) | 2007-05-07 | 2008-11-13 | Massachusetts Institute Of Technology | Polymer sheets and other bodies having oriented chains and method and apparatus for producing same |
EP2405022A3 (de) * | 2008-07-08 | 2012-05-02 | Genomic Health, Inc. | Genexpressionsprofilierung zur Vorhersage der Überlebensfähigkeit von Prostatakrebspatienten |
WO2010096486A1 (en) | 2009-02-17 | 2010-08-26 | Cornell Research Foundation, Inc. | Methods and kits for diagnosis of cancer and prediction of therapeutic value |
JP5222906B2 (ja) * | 2010-07-20 | 2013-06-26 | 株式会社日立ハイテクノロジーズ | 生体試料の分析方法 |
CN102998448A (zh) * | 2011-09-09 | 2013-03-27 | 上海市计划生育科学研究所 | 来源于前列腺分泌液中的前列腺癌标记物 |
CN102409091A (zh) * | 2011-10-17 | 2012-04-11 | 刘颜 | 前列腺分泌蛋白94/57作为卵巢癌、乳腺癌早期临床诊断生物标记物的方法 |
EA030682B1 (ru) | 2012-03-05 | 2018-09-28 | Ой Арктик Партнерс Аб | Способы и аппараты для прогнозирования риска рака предстательной железы и объема предстательной железы |
JP5429725B1 (ja) * | 2013-03-22 | 2014-02-26 | 独立行政法人理化学研究所 | 前立腺癌の進行度の評価方法、前立腺癌の検出方法、および検査キット |
EP2806275B1 (de) | 2013-05-23 | 2015-07-01 | Bruker Daltonik GmbH | Massenspektrometrische Resistenzbestimmung durch Wachstums-Messung |
MY192513A (en) | 2014-03-28 | 2022-08-24 | Opko Diagnostics Llc | Compositions and methods related to diagnosis of prostate cancer |
GB2535835B (en) * | 2014-12-17 | 2019-09-04 | Micromass Ltd | A two-dimensional separation and imaging technique for the rapid analysis of biological samples |
PL3253800T3 (pl) | 2015-03-27 | 2021-08-23 | Opko Diagnostics, Llc | Standardy antygenów prostaty i ich zastosowanie |
AU2020326698A1 (en) | 2019-08-05 | 2022-02-24 | Seer, Inc. | Systems and methods for sample preparation, data generation, and protein corona analysis |
GB202111635D0 (en) * | 2021-08-13 | 2021-09-29 | Randox Laboratories | Risk prediction model for prostate cancer |
CN114292918A (zh) * | 2021-12-31 | 2022-04-08 | 刘飞 | 一种基于LncRNA546标志物的前列腺癌早期诊断方法 |
CN115711933A (zh) * | 2022-11-10 | 2023-02-24 | 广东省人民医院 | 检测试剂、检测试剂盒及其应用 |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1757694A3 (de) * | 1992-11-05 | 2008-02-27 | Sloan Kettering Institute For Cancer Research | Prostata-spezifisches Membranantigen |
WO1998040513A1 (en) * | 1997-03-11 | 1998-09-17 | Ferrari Anna C | Method of detecting prostate cancer metastasis |
WO2000050457A1 (en) * | 1999-02-22 | 2000-08-31 | Beckman Coulter, Inc. | Prostate-specific membrane antigens and methods of making and using |
CN1426536A (zh) * | 2000-03-20 | 2003-06-25 | 东弗吉尼亚医学院 | 前列腺癌标记 |
US6379550B1 (en) * | 2000-07-24 | 2002-04-30 | Health Research, Inc. | Method for detecting PSA and its molecular forms using thiophilic gel |
-
2001
- 2001-11-16 AT AT01989101T patent/ATE362107T1/de not_active IP Right Cessation
- 2001-11-16 CA CA002428011A patent/CA2428011A1/en not_active Abandoned
- 2001-11-16 KR KR10-2003-7006792A patent/KR20030066672A/ko not_active Application Discontinuation
- 2001-11-16 EP EP01989101A patent/EP1390523B1/de not_active Expired - Lifetime
- 2001-11-16 DE DE60128404T patent/DE60128404D1/de not_active Expired - Lifetime
- 2001-11-16 AU AU4322102A patent/AU4322102A/xx active Pending
- 2001-11-16 AU AU2002243221A patent/AU2002243221B2/en not_active Ceased
- 2001-11-16 WO PCT/US2001/043424 patent/WO2002046448A2/en active IP Right Grant
- 2001-11-16 JP JP2002548165A patent/JP2004536278A/ja active Pending
- 2001-11-16 CN CNA018216579A patent/CN1537170A/zh active Pending
Also Published As
Publication number | Publication date |
---|---|
CA2428011A1 (en) | 2002-06-13 |
EP1390523A2 (de) | 2004-02-25 |
AU2002243221B2 (en) | 2006-11-09 |
AU4322102A (en) | 2002-06-18 |
EP1390523B1 (de) | 2007-05-09 |
DE60128404D1 (de) | 2007-06-21 |
WO2002046448A2 (en) | 2002-06-13 |
KR20030066672A (ko) | 2003-08-09 |
JP2004536278A (ja) | 2004-12-02 |
EP1390523A4 (de) | 2004-03-31 |
WO2002046448A3 (en) | 2003-12-11 |
CN1537170A (zh) | 2004-10-13 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE362107T1 (de) | Verfahren und vorrichtungen zum quantitativen nachweis eines prostata-spezifischen membranantigens und anderer prostatamarker | |
ATE333517T1 (de) | Verfahren und sondenset zur erkennung von krebs | |
DE60142254D1 (de) | Zusammensetzungen, methoden und reagentien zur nukleinsäureisolierung mittels oberflächenaktiven substanzen und proteasen | |
ATE212674T1 (de) | Verfahren und analytisches system zur genauen schnellen und einfachen ausführung von fibrinogen-assays | |
ATE350488T1 (de) | Verfahren und testsysteme zur identifizierung von elite event gat-zm1 in biologischen proben | |
DE50312579D1 (de) | Vorrichtung zur Detektion von Targetmolekülen | |
ATE385259T1 (de) | Verfahren zum nachweis von influenza a/b-viren in speichel | |
DE59609347D1 (de) | Verfahren zur quantifizierung von tumorzellen in einer körperflüssigkeit und dazu geeignete testkits | |
GB2431988A (en) | Assay device & method | |
AU2002303444A1 (en) | Detection of microsatellite instability and its use in diagnosis of tumors | |
DK0975800T3 (da) | Analyse af nukleotider i opløsning under anvendelse af PNA-prober | |
WO2002048674A3 (en) | Methods, devices, arrays and kits for detecting and analyzing biomolecules | |
DE60217351D1 (de) | Verfahren zur identifizierung von proben eines säugetiers als auch ein kit zur durchführung des verfahrens | |
AU2003260457A1 (en) | A method and kit for the quantitative and/or qualitative detection of components in a sample | |
DE60228952D1 (de) | Nachweis von Legionella durch ein PCR und FRET verwendendes Verfahren | |
DE60012723D1 (de) | Verfahren zur bestimmung von disaccharidasen | |
SE0002287D0 (sv) | Biotinderivat | |
DE50110172D1 (de) | Verfahren zur altersbestimmung von individuen | |
DK1337849T3 (da) | Fremgangsmåder og sammensætninger til at sortere og/eller bestemme mikroorganismer | |
ATE486964T1 (de) | Molekulares verfahren zur diagnose von prostatakrebs | |
ATE292283T1 (de) | Verfahren zur immobilisierung von affinen reagentien an hydrophoben festphasen | |
PT1218749E (pt) | Sistema de deteccao de cancro da prostata atraves da analise do psa/igf-l livre | |
EP1724579A3 (de) | Verfahren zur Diagnose von Prostatakrebs und zur Analyse von Prostatatumoren | |
DK1664330T3 (da) | Blod- og urintest | |
ATE391914T1 (de) | Assay |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |